UNSW News berichtet über einen individualisierten Krebsfall bei Hunden mit einem personalisierten mRNA-Impfstoffansatz und unterschiedlichen Tumorreaktionen

For context, this UNSW article describes an individualized canine cancer case, not a clinical trial, so it should not be read as proof of efficacy.

It involved tumour profiling, computational analysis, and a personalised mRNA vaccine approach in the context of treatment. Reported responses were not uniform across tumours, and the relative contributions of the vaccine, checkpoint therapy, and their interaction remain unresolved.

Disclosure: I provided scientific/genomics guidance on this case based on the data and information shared with our team. The case itself was led by Paul, who holds the full case-specific and operational details. I’m happy to clarify the scientific aspects where useful.